Plain‑language drug resistant epilepsy research: who benefits from surgery, devices, diets, and emerging treatments.
A study was conducted to evaluate the effectiveness and safety of a medication called cenobamate (CNB) in treating patients with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy that often starts in childhood.
This study looked at how children aged 8 to 17 experience long-term video-electroencephalography monitoring (LTVEM), a procedure used to diagnose epilepsy when medications don’t work.
This study looked at a specific gene called ADAM23 and its potential role in causing focal epilepsy, which is a type of seizure disorder.
Researchers studied the effects of a new treatment called repetitive transcranial magnetic stimulation (rTMS) on dogs with drug-resistant epilepsy.
Researchers conducted a systematic review to explore how advanced imaging techniques can identify neuro-inflammatory biomarkers in people with epilepsy who do not respond to medication.
Researchers studied how to create a standard way to measure recovery in adults with epilepsy who also have depression or anxiety.
This study looked at how well ultra-high field 7T MRI works for children with drug-resistant focal epilepsy.
Researchers studied the effectiveness of antiseizure medications (ASMs) for treating epilepsy in children with Cyclin-dependent kinase-like 5 deficiency disorder (CDD), a serious condition that often leads to drug-resistant seizures.
This study focused on children with tuberous sclerosis complex (TSC) who experience epilepsy.